Knowledge mapping of ⁹⁰Y transarterial radioembolization combined with immunotherapy in hepatocellular carcinoma: a bibliometric analysis
Discover Oncology · 07.05.2026 · 17 (1)
DOI: 10.1007/s12672-026-05154-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 07.05.2026. Verfasst von Song-Nian He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Medical School, Zhongda Hospital, Southeast University, 87 Dingjiaq…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Jiangsu Provincial Medical Innovation Center.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a highly aggressive malignancy with substantial mortality globally. The synergistic potential between immunotherapy and yttrium-90 transarterial radioembolization (⁹⁰Y-TARE) has stimulated extensive research into HCC combined therapeutic strategies. However, a comprehensive bibliometric analysis elucidating the evolutionary trajectory, research trends, and collaborative networks within this field remains absent. Unlike conventional systematic reviews, which are inherently subjective and lack the capacity for large-scale quantitative synthesis, bibliometric analysis offers a robust, data-driven approach to construct a holistic knowledge atlas. A total of 143 relevant publications were extracted from the Web of Science Core Collection (WoSCC) database, spanning 1 January 2003 to 24 October 2025. Utilizing VOSviewer, CiteSpace, and the R package bibliometrix, a multidimensional analysis encompassing publication volume, journal impact, national/contributions, institutional collaborations, authorship networks, co-citation patterns, and keyword clustering was conducted. From 2015 to 2025, the number of publications in this field has steadily increased. The United States was the dominant contributor. Global institutional collaboration was limited, highlighting the need for multinational cooperation. Co-citation and keyword analyses revealed three research frontiers: mechanisms of radio-immunologic synergy, optimization of treatment sequencing and dosimetry, and predictive biomarker development. Future research requires more phase III trials, incorporating multi-omics technologies and individualized dosimetry models to validate survival benefits and explore more precise immuno-combination strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Medical School, Zhongda Hospital, Southeast University, 87 Dingjiaqiao Road, Nanjing, 210009, China.
- National Innovation Platform for Integration of Medical Engineering Education (NMEE) (Southeast University), Nanjing, 210009, China.
- Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Medical School, Zhongda Hospital, Southeast University, 87 Dingjiaqiao Road, Nanjing, 210009, China. zhuhaidong9509@163.com.
- National Innovation Platform for Integration of Medical Engineering Education (NMEE) (Southeast University), Nanjing, 210009, China. zhuhaidong9509@163.com.
- Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology, Southeast University), Nanjing, 210009, China. zhuhaidong9509@163.com.
- Basic Medicine Research and Innovation Center of Ministry of Education, Zhongda Hospital, Southeast University, Nanjing, 210009, China. zhuhaidong9509@163.com.
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Jiangsu Provincial Medical Innovation Center
- The Natural Science Foundation of Jiangsu Province
Zitieren
APA
He, S. N., Zeng, C. H., Du, R. J., Yang, Y. X., & Zhu, H. D. (2026). Knowledge mapping of ⁹⁰Y transarterial radioembolization combined with immunotherapy in hepatocellular carcinoma: a bibliometric analysis. Discover Oncology, 17(1). https://doi.org/10.1007/s12672-026-05154-2
Vancouver
He SN, Zeng CH, Du RJ, Yang YX, Zhu HD. Knowledge mapping of ⁹⁰Y transarterial radioembolization combined with immunotherapy in hepatocellular carcinoma: a bibliometric analysis. Discover Oncology. 2026;17(1). doi:10.1007/s12672-026-05154-2
BibTeX
@article{He2026,
author = {He, Song-Nian and Zeng, Chu-Hui and Du, Rui-Jie and Yang, Yi-Xuan and Zhu, Hai-Dong},
title = {Knowledge mapping of ⁹⁰Y transarterial radioembolization combined with immunotherapy in hepatocellular carcinoma: a bibliometric analysis},
journal = {Discover Oncology},
year = {2026},
volume = {17},
number = {1},
doi = {10.1007/s12672-026-05154-2}
}
EUVIMED